(Q46266418)

English

Diet, physical exercise and Orlistat administration increase serum anti-Müllerian hormone (AMH) levels in women with polycystic ovary syndrome (PCOS).

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/23194076

Diet, physical exercise and Orlistat administration increase serum anti-Müllerian hormone (AMH) levels in women with polycystic ovary syndrome (PCOS). (English)

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/23194076

polycystic ovary syndrome

1 reference

based on heuristic

inferred from title

polycystic ovary

1 reference

based on heuristic

inferred from title

author name string

Christos Vosnakis

1

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/23194076

Neoklis A Georgopoulos

2

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/23194076

David Rousso

3

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/23194076

Georgios Mavromatidis

4

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/23194076

Ilias Katsikis

5

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/23194076

Nikolaos D Roupas

6

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/23194076

Irene Mamali

7

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/23194076

Dimitrios Panidis

8

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/23194076

publication date

30 November 2012

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/23194076

Gynecological Endocrinology

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/23194076

29

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/23194076

3

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/23194076

242-245

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/23194076

Polycystic Ovary Syndrome

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.736557

21 January 2018

A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.736557

21 January 2018

Dietary composition in restoring reproductive and metabolic physiology in overweight women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.736557

21 January 2018

Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.736557

21 January 2018

Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.736557

21 January 2018

Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.736557

21 January 2018

The impact of oral contraceptives and metformin on anti-Müllerian hormone serum levels in women with polycystic ovary syndrome and biochemical hyperandrogenemia.

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.736557

21 January 2018

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.736557

21 January 2018

Müllerian-inhibiting substance in follicular fluid and serum: a comparison of patients with tubal factor infertility, polycystic ovary syndrome, and endometriosis.

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.736557

21 January 2018

Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest.

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.736557

21 January 2018

Mullerian-inhibiting substance in women with polycystic ovary syndrome: relationship with hormonal and metabolic characteristics

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.736557

21 January 2018

Association of anti-mullerian hormone levels with obesity in late reproductive-age women.

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.736557

21 January 2018

Granulosa cell production of anti-Müllerian hormone is increased in polycystic ovaries.

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.736557

21 January 2018

Serum luteinizing hormone levels are markedly increased and significantly correlated with Delta 4-androstenedione levels in lean women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.736557

21 January 2018

Mullerian Inhibiting Substance is an ovarian growth factor of emerging clinical significance

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.736557

21 January 2018

Serum anti-Müllerian hormone (AMH) levels are differentially modulated by both serum gonadotropins and not only by serum follicle stimulating hormone (FSH) levels

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.736557

21 January 2018

Metformin reduces serum mullerian-inhibiting substance levels in women with polycystic ovary syndrome after protracted treatment

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.736557

21 January 2018

Phenotypic expression, body mass index and insulin resistance in relation to LH levels in women with polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.736557

21 January 2018

Fat digestion is required for suppression of ghrelin and stimulation of peptide YY and pancreatic polypeptide secretion by intraduodenal lipid

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.736557

21 January 2018

Association of ghrelin and leptin with reproductive hormones in constitutional delay of growth and puberty

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.736557

21 January 2018

Identifiers

10.3109/09513590.2012.736557

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/23194076

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/23194076

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46266418&oldid=1588302462"